Sagimet Biosciences (SGMT) Change in Acquisitions & Divestments (2022 - 2026)

Sagimet Biosciences' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $17.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 10.64% year-over-year to $17.0 million; the TTM figure through Mar 2026 stood at $109.4 million (up 75.34% YoY), while the FY2025 annual figure was $111.4 million, up 140.11% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $17.0 million, down from $31.4 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $31.4 million in Q4 2025, with the low at $3.0 million in Q1 2024.
• The 5-year median for Change in Acquisitions & Divestments is $18.0 million (2025), against an average of $17.7 million.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments sank 84.54% in 2024, then surged 532.93% in 2025.
• Sagimet Biosciences' Change in Acquisitions & Divestments stood at $5.4 million in 2022, then jumped by 135.47% to $12.8 million in 2023, then jumped by 84.44% to $23.6 million in 2024, then jumped by 33.15% to $31.4 million in 2025, then slumped by 46.02% to $17.0 million in 2026.
• Business Quant data shows SGMT's Change in Acquisitions & Divestments at $17.0 million in Q1 2026, $31.4 million in Q4 2025, and $31.3 million in Q3 2025.